High expression of CD39 in gastric cancer reduces patient outcome following radical resectionXiaoyan Cai(Shanghai Pudong New Area Gongli Hospital), Yihong Sun(Fudan University)Oncology LettersSeptember 26, 201610.3892/ol.2016.5189Cited by 57SaveCiteExport RISWatch citationsRelated PapersThe Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction|Nature Communications|2022|82